News & Events
News
ENABLING Project ends after 36 months of Active engagement in the Bioeconomy
29-11-2020
European Union’s Horizon 2020
PRESS RELEASE
Final Conference
The ENABLING Final Conference was held at EIMA Digital Preview on November 13, 2020. The EIMA Digital Preview -was the virtual fair organised by Federunacoma as a pre-event to the EIMA International Fair 2020, which was to be held in November. EIMA will now be held in February 2021, due to COVID-19 related impediments.
Migal took part in the inauguration of the Pafos Innovation Institute
05-11-2020
The Pafos Innovation Institute (PII) for higher education
Senior researcher Prof. Michael (Iggy) Litaur will lead the academic and the scientific aspects of the Integrative Water Management Program for postgraduate degrees: MBA MA and will be managed by IDC, in collaboration with other leading institutions and researchers from the Middle East and the world.
Researchers
Call for Senior Research Scientist positions
01-10-2020
Migal Galilee Research Institute Ltd
MIGAL Galilee Research Institute invites applicants for a Research Group Leader position in the following disciplinary areas: Organic Chemistry, Soil Chemistry, Computational/Synthetic Biology, Immunology, Plant Sciences/Health food value, Plant Genomics
The potential use of natural products to negate hepatic, renal and neuronal toxicity induced by cancer therapeutics
01-03-2020
Biochemical Pharmacology
Patrik Prša, Betül Karademir, Gökhan Biçim, Hatem Mahmoud, Inbal Dahan, Süha Yalçın, Jamal Mahajna, Irina Milisava (2019). The potential use of natural products to negate hepatic, renal and neuronal toxicity induced by cancer therapeutics. Biochemical Pharmacology, Volume 173.
Researchers
Research Groups
Initiated by UAE - First online professional symposium with Israeli CEO of the MIGAL Institute
07-09-2020
TRENDS Research and Advisory
Initiated by the UAE - First online professional symposium with the participation of an Israeli, CEO of the MIGAL Institute, and other global experts to develop a COVID-19 vaccine
By Dana Elimelech
Researchers from the MIGAL Institute use the Oracle Cloud as part of their fight against COVID-19
14-09-2020
SoftNews
The MIGAL Galilee Research Institute, which is developing a vaccine for the novel coronavirus via its subsidiary MigVax, uses the Oracle Cloud Infrastructure to support its research efforts as part of the global mobilization to combat COVID-19. As part of the development process, the researchers have been analyzing huge databases of viral genetic sequences in order to identify the virus’s weaknesses.
Researchers
Research Groups
Zebrafish help scientists speed up tests for medical cannabis strains
09-09-2020
ISRAEL 21c
Unusual research approach speeds up discovery of which cannabis plants work best for which medical indications.
Different strains of cannabis are helpful for treating different medical conditions. Testing each type for its therapeutic potential using mice or people is time-consuming.
WARNING!! Fraud Notice – Covid-19 Product
26-05-2020
Migal Galilee Research Institute Ltd., Migvax Ltd.
We have just been made aware that a fake pharmaceutical product allegedly for use in connection with COVID-19 is fraudulently being advertised and apparently sold in South America with the logo of Migal and with the following wording: " COVID-19 vaccine tracker. Cutting edge Israeli Biotech innovating coronavirus immunotherapy treatments." A photograph appears below.
Breakthrough from Israel’s MIGAL Research Institute in Development of Corona virus (COVID-19) Vaccine
27-02-2020
Israel’s Ministry of Science & Technology
After four years of research funded by Israel’s Ministry of Science & Technology, MIGAL’s researchers have developed an effective vaccine against avian coronavirus Infectious Bronchitis Virus (IBV), to be adapted soon and create a human vaccine against COVID-19
Research Groups
COVIS-19Coronavírus: vacina pode ser criada em 90 dias, diz instituto de Israel
19-03-2020
Por Márcio Juliboni
Contra o tempo: cientistas israelenses afirmam estar perto de obter vacina contra o coronavírus (Imagem: Unsplash/@cdc)
Uma vacina contra o coronavírus pode ser criada em 90 dias. A afirmação foi feita por David Zigdon, CEO do Galilee Research Institute (Migal), localizado na Galileia, em Israel. Zigdon participou de uma entrevista coletiva nesta quinta-feira (27), junto com sua equipe, para anunciar avanços nas pesquisas.
COVID-19
28-02-2020
Newsweek
CORONAVIRUS VACCINE 'WEEKS' AWAY FROM BEING DEVELOPED, SAYS HEAD OF ISRAELI SCIENCE RESEARCH INSTITUTE
The new virus that has killed over 2,800 people is a member of the large coronavirus family of pathogens, which also includes SARS and MERS.
Researchers
Research Groups